The largest database of trusted experimental protocols

Hypoxanthine aminopterin thymidine supplemented medium

Manufactured by Merck Group

Hypoxanthine-Aminopterin-Thymidine (HAT) supplemented medium is a cell culture supplement used to support the growth and selection of hybridoma cells. It contains hypoxanthine, aminopterin, and thymidine, which are essential components for the survival and proliferation of cells.

Automatically generated - may contain errors

2 protocols using hypoxanthine aminopterin thymidine supplemented medium

1

Monoclonal antibody generation protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nucleic acid gel imaging system, nucleic acid electrophoresis apparatus and protein gel electrophoresis apparatus were purchased from Shanghai Tanon company. Microplate reader was purchased from Thermo Fisher Technology Ltd (Shanghai, China). Polyethylene glycol(PEG) was purchased from Merck Co, Mouse typerisotyping panel kit from Bio-RAD Co, and RPMI MEDIEM 1640 medium, penicillin-Streptomycin double antibody solution, newborn calf serum and HEPES from Life Technologies Gibco Co. Hypoxanthine-Aminopterin-Thymidine (HAT) supplemented medium, Hypoxanthine- Thymidine (HT) supplemented medium, Freund's complete or incomplete adjutants were purchased from Sigma. Natural human cystatin C (N-HCC) was purchased from Enzo Life Sciences Ltd., Horseradish peroxidase-conjugated goat anti-mouse IgG from Santa Cruz Biotechnology Inc., or Tween-20 and Bovine serum albumin (BSA) from Amresco. BALB/c mice were from Shanghai Institutes for Biological Nutrition, according to the ethical permission approved by the committee of Animal Ethical Evaluation, Chinese Academy of Science. The natural camel single-domain heavy chain antibody library was kindly provided by Dr. Ario de Marco for Italian IFOM-IEO center.
+ Open protocol
+ Expand
2

Generating DYS-HAC3 via Cre/LoxP and Bxb1 systems

Check if the same lab product or an alternative is used in the 5 most similar protocols
2 × 106 CHO(DYS‐HAC2) cells were co‐transfected with p17 (8 μg) and Cre‐expressing plasmids (1 μg) using Lipofectamine 2000 (Invitrogen) to induce insertion of p17 into DYS‐HAC2 via Cre/LoxP system and generate DYS‐HAC3. 24 h after transfection, CHO cells were expanded with a hypoxanthine–aminopterin–thymidine (HAT)‐supplemented medium (Sigma‐Aldrich) to select only CHO cells containing DYS‐HAC3. CHO(DYS‐HAC3) cells were further transfected with pP‐ΔHR and Bxb1‐expressing plasmid following the same protocol detailed above. Selection was performed according to the following: 8 μg of blasticidin S (Wako), 800 μg of G418 (Promega), 7 mM of L‐histidinol dihydrochloride (Sigma‐Aldrich) and HAT medium.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!